Back to CADL

Candel Therapeutics, Inc. 10-Q

Accession 0000950170-23-061566

Filing information

CIK
0001841387
Report date
2023-09-30
Filing date
2023-11-09
Form
10-Q
Primary document
cadl-20230930.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.